![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Buy article online]](/logos/buy.gif)
![[Contents scheme]](ob6128contents.gif)
Acta Cryst. (2002). E58, m231-m233 [ doi:10.1107/S1600536802007493 ]
-Bis(salicylidene)-1,3-propanediaminato]bis(N,N-dimethylformamide)nickel(II)}diiodozinc(II) Abstract: In the crystal structure of the title molecule, [NiZnI2(C17H16N2O2)(C3H7NO)2], Ni2+ and Zn2+ ions are bridged by the two phenolic O atoms of the N,N'-bis(salicylidene)-2,2-dimethyl-1,3-propanediaminate (salpd2-, C17H16N2O22-) ligand. The Ni2+ ion has an irregular octahedral geometry involving two phenolic O and two iminic N atoms of the salpd2- in the equatorial plane. The compound includes two DMF (dimethylformamide) solvent molecules coordinated to the Ni2+ ion at the apical position. The coordination around the Zn2+ ion is distorted tetrahedral, involving two bridging O atoms and two I atoms.
Online 30 April 2002
Copyright © International Union of Crystallography
IUCr Webmaster